Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease

Yue, Xin; Black, Carla L.; Lu, Peng–jun; Williams, Walter W.; Nelson, Noele P.

doi:10.1016/j.vaccine.2018.01.033

Cited by 22 publications

(21 citation statements)

References 19 publications

(26 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Adherence to influenza vaccination in this survey was similar to that observed in Spain among subjects with high-risk chronic conditions [23]. In the US, 37%, 39%, and 41% of patients with diabetes were immunized against pneumococcal disease, hepatitis B, and influenza, respectively [26] and 35.7% and 29.1% of adults aged ≥18 years with chronic liver disease reported having received ≥1 dose and ≥3 doses of hepatitis B vaccine, respectively [24], whereas in this sample only one in five with chronic hepatitis had been immunized against hepatitis B. The low adherence underlined the need for a stronger engagement of specialists, for example in public outpatient clinics, in preventive activities by recording chronic non-immunized patients and actively offering the vaccines.…”

Section: Discussionsupporting

confidence: 76%

Vaccinations and Chronic Diseases: Knowledge, Attitudes, and Self-Reported Adherence among Patients in Italy

et al. 2020

View full text Add to dashboard Cite

The aims of this cross-sectional survey were to evaluate the knowledge, attitudes, and self-reported adherence to recommended vaccinations among a random sample of patients with chronic conditions presenting for a medical visit in out-patient clinics in Italy. Patients who were healthcare workers (HCWs), those with diabetes, those who had received information by Internet, physicians, and friends/relatives, and those who needed more information were more likely to know that the influenza vaccine is recommended for patients with chronic diseases. More than half (58.2%) and 8.9% self-reported to have received at least one recommended vaccination and more than one, respectively. Patients who believed that vaccine-preventable diseases (VPDs) were dangerous for them, those who had received information by physicians, and those who needed information were more likely to have received at least one recommended vaccination. This behavior was less likely in married patients, those who were worried about the side effects of the vaccines, and those who suffered from renal failure. The results highlight the need to implement effective vaccination programs in order to decrease the complication of VPDs in at-risk population.

show abstract

Section: Discussionsupporting

confidence: 76%

Vaccinations and Chronic Diseases: Knowledge, Attitudes, and Self-Reported Adherence among Patients in Italy

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Prior studies have reported suboptimal rates of series completion for hepatitis vaccine also in defined subpopulations, including patients with chronic liver disease [16], former prisoners [14], intravenous drug users [21], the homeless [22], and travelers [15, 23, 24]. Most of these studies did not examine series completion with regard to the recommended timelines.…”

Section: Discussionmentioning

confidence: 99%

“…Studies of adults in countries of low hepatitis prevalence, such as the UK, United States (US), Canada, and western Europe, indicate that hepatitis A and B vaccine series completion rates among adults are low [11–16]. For example, in a large 2015 survey in the US, only 16 and 32% of travelers to countries of high to intermediate endemicity had completed the two- or three-dose series for hepatitis A or hepatitis B, respectively [11].…”

Section: Introductionmentioning

confidence: 99%

“…For example, in a large 2015 survey in the US, only 16 and 32% of travelers to countries of high to intermediate endemicity had completed the two- or three-dose series for hepatitis A or hepatitis B, respectively [11]. The majority of studies of hepatitis vaccine series completion, however, are done in circumscribed populations such as the homeless [14], travelers [15], and adults with chronic liver disease [16].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Adherence to hepatitis A and hepatitis B multi-dose vaccination schedules among adults in the United Kingdom: a retrospective cohort study

Johnson

Lu²,

Zhang

2019

BMC Public Health

View full text Add to dashboard Cite

Background Timely and complete vaccination with multi-dose schedules is of public health importance, because an incomplete vaccination series may yield suboptimal disease protection. However, data on adherence of adults to multi-dose vaccines are limited. We sought to estimate adherence to multi-dose hepatitis vaccination schedules among adults in the United Kingdom (UK). Methods This retrospective cohort study was conducted using anonymized electronic health record (EHR) data from the Clinical Practice Research Datalink (CPRD). Individuals aged 19 years and older at their first identified dose of hepatitis vaccine (2009–2016) were included if they had continuous EHR data for 12 months before the first identified hepatitis A dose or for 6 months before the first identified hepatitis B or combination hepatitis A/B dose. We estimated dose and series completion for each vaccine and adherence to recommended vaccination schedules, as well as adherence within additional prespecified time periods after the first vaccine dose, with sensitivity analyses restricted to adults who had available data for up to 24 months after the first dose. Median time to series completion was estimated using Kaplan-Meier methods. Results Mean (SD) age at initiation was 42 (16) years for hepatitis A ( n = 374,881), 40 (16) years for hepatitis B ( n = 71,634), and 38 (15) years for hepatitis A/B ( n = 10,335). Women comprised 52 to 55% of each vaccine cohort. Overall, 42,294 adults (11%) completed the two-dose hepatitis A vaccine series within the recommended 12 months; and 15,564 (22%) and 1076 (10%) completed the three-dose hepatitis B and hepatitis A/B series, respectively, within the recommended 6 months. These percentages rose to only 23, 35, and 33%, respectively, when the follow-up periods were extended to 36 months for hepatitis A and to 30 months for hepatitis B and A/B vaccines. Median times to series completion within recommended schedules were not reached in any cohort. Sensitivity analyses supported the primary findings for the full cohorts. Conclusions Adherence and series completion rates for hepatitis A and B vaccines in the UK are low. Identifying, understanding, and addressing barriers to series completion for multi-dose vaccines for adults in real-world settings are needed. Electronic supplementary material The online version of this article (10.1186/s12889-019-6693-5) contains supplementary material, which is available to authorized users.

show abstract

“…Even among those with ≥10 provider visits, only 13.8% had received two doses of HepA vaccine, indicating missed opportunities for vaccination. 9…”

mentioning

confidence: 99%

Need for Increasing Hepatitis A Virus Vaccination Among Patients Infected With Hepatitis B Virus and Hepatitis C Virus

et al. 2018

Self Cite

View full text Add to dashboard Cite

Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease

Cited by 22 publications

References 19 publications

Vaccinations and Chronic Diseases: Knowledge, Attitudes, and Self-Reported Adherence among Patients in Italy

Vaccinations and Chronic Diseases: Knowledge, Attitudes, and Self-Reported Adherence among Patients in Italy

Adherence to hepatitis A and hepatitis B multi-dose vaccination schedules among adults in the United Kingdom: a retrospective cohort study

Need for Increasing Hepatitis A Virus Vaccination Among Patients Infected With Hepatitis B Virus and Hepatitis C Virus

Contact Info

Product

Resources

About